Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMAGINE depemokimab airway structure and function substudy in eosinophilic type 2 asthma
CTR20254205Phase 3Active
- Sponsor
- GSK
- Start
- Oct 2025
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of depemokimab in asthma, sponsored by GSK. Started Oct 2025; status: active.
02
Drugs
depemokimab
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20254205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20254205.